MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$124,220K
Prepaid expenses and
other current assets
$8,435K
Other receivables
$177K
Total current assets
$132,832K
Operating right-of-use
asset
$5,535K
Other non-current
assets
$4,378K
Property and equipment,
net
$3,733K
Total assets
$146,478K
Total liabilities and
stockholders equity
$146,478K
Total liabilities
$138,485K
Total stockholders
equity
$7,993K
Accumulated deficit
-$246,187K
Long-term debt, including
final payment fee
$100,559K
Total current
liabilities
$33,799K
Non-current portion of
operating lease liability
$4,127K
Additional
paid-in-capital
$254,179K
Common stock, 0.0001
par value,...
$1K
Accrued expenses
$25,529K
Accounts payable
$5,944K
Current portion of
operating lease liability
$2,326K
Back
Back
Balance Sheet
source: myfinsight.com
Inhibrx Biosciences, Inc. (INBX)
Inhibrx Biosciences, Inc. (INBX)